Breast implant maker used non-approved gels: lawyer

December 27, 2011 in Other

The founder of the French firm that made breast implants feared to be at risk of rupturing has admitted using non-approved but non-toxic silicone gels, his lawyer said Tuesday.

Jean-Claude Mas's now-bankrupt company, Poly Implant Prosthese (PIP), was shut down and its products banned in April 2010 after it was revealed to have been using non-authorised silicone gel that caused abnormally high implant rupture rates.

Yves Haddad, a lawyer for the 72-year-old, said his client was at home in the south of France. Mas could not appear in public because of and problems walking.

Haddad said Mas acknowledges using unapproved silicon gel, but is adamant it is safe.

"PIP knew it wasn't in compliance, but it wasn't a toxic product," the lawyer said, adding it "had not been proven" the implants were any more likely to leak.

PIP used two types of silicone in its implants, Haddad said. One of them was an approved gel made by American firm Nusil, but it also used a homemade gel that was five times cheaper for the cash-strapped PIP, which filed for bankruptcy in 2010.

Haddad said the gel was chemically identical to Nusil.

In 2000, a representative from the US visited PIP, Haddad said. Following the visit, PIP products were banned in the US.

Documents obtained by AFP showed tens of thousands of women in more than 65 countries, mainly in South America and western Europe, received implants produced by PIP.

According to PIP's 2010 , it had exported 84 percent of its annual production of 100,000 implants.

France's has advised 30,000 women in France with PIP implants to have them removed, saying that while there is no proven , the could rupture.

Any woman who declines the removal must have a breast scan every six months, the ministry added.

Prosecutors in Marseille, near PIP's home base of Seyne-sur-Mer, have received more than 2,000 complaints from Frenchwomen who received the implants, and have opened a criminal investigation into the firm.

Prosecutors have interviewed about 15 people in the case and a trial is expected next year for "aggravated deceit."

Mas was among the first to develop in France, initially producing saline-based prostheses, Haddad said.

(c) 2011 AFP

not rated yet  

Rank not rated yet
Related Stories
Relevant PhysicsForums posts

More news stories

Flesh-eating disease victim gets prosthetic hands

(AP)—A woman who lost both hands, her left leg and right foot after contracting a flesh-eating disease has been fitted with prosthetic hands.

Other created May 18, 2013 | popularity not rated yet | comments 0

Illinois Senate approves medical marijuana bill

(AP)—Medical marijuana use in Illinois is now in Gov. Pat Quinn's hands after the state Senate approved legislation.

Other created May 17, 2013 | popularity 5 / 5 (1) | comments 0

Nigerian court jails two over killer teething drug

A Nigerian court on Friday sentenced two officials from a pharmaceutical company to seven years in prison over the sale of an adulterated teething drug which killed 84 babies in 2008.

Other created May 17, 2013 | popularity not rated yet | comments 0

Many patients would switch doc to cut health care costs

(HealthDay)—Many Americans feel that keeping out-of-pocket health care costs is more important than staying with the same primary care physician.

Other created May 17, 2013 | popularity not rated yet | comments 0

Cultural attitudes impede organ donations in China

(AP)—China is phasing out its reliance on executed prisoners for donated organs, but an architect of the country's transplant system said Friday that ingrained cultural attitudes are impeding the rise of ...

Other created May 17, 2013 | popularity not rated yet | comments 0


Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.

Consuming coffee linked to lower risk of detrimental liver disease, study finds

Regular consumption of coffee is associated with a reduced risk of primary sclerosing cholangitis (PSC), an autoimmune liver disease, Mayo Clinic research shows. The findings were being presented at the Digestive Disease ...

Ketamine shows significant therapeutic benefit in people with treatment-resistant depression

Patients with treatment-resistant major depression saw dramatic improvement in their illness after treatment with ketamine, an anesthetic, according to the largest ketamine clinical trial to-date led by researchers from the ...

Research examines new methods for managing digestive health

Research presented at Digestive Disease Week (DDW) explores new methods for managing digestive health through diet and lifestyle.

New smartphone application improves colonoscopy preparation

The use of a smartphone application significantly improves patients' preparation for a colonoscopy, according to new research presented today at Digestive Disease Week (DDW). The preparation process, which begins days in ...